Source link : https://newshealth.biz/health-news/new-fda-approved-option-for-her2-mutated-lung-cancer/
(MedPage Today) — The FDA announced accelerated approval of sevabertinib (Hyrnuo) for HER2-positive non-small cell lung cancer (NSCLC). The approval stipulates use in patients who already have received systemic therapy for NSCLC. At the same… Source link : https://www.medpagetoday.com/hematologyoncology/lungcancer/118608 Author : Publish date : 2025-11-19 21:19:00 Copyright for syndicated content belongs to the linked Source.
The post New FDA-Approved Option for HER2-Mutated Lung Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2025-11-19 21:19:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8